Value Satoris Brings

Differences that matter.

Satoris biomarker tests provide the pharmaceutical community with protein panels — clusters of biomarkers that are especially useful in heterogenous and dynamic diseases. In addition to being used for diagnosis, these clusters are also potential targets for future therapies.

• Minimal sample preparation and fewer process steps than nucleic acid or mass spec procedures.
• Antibody-based analysis enables the identification and quantification of individual proteins associated with a particular disease state.
• Multivariate analysis, as opposed to tests based on only one or two biomarkers, with demonstrated ~90% accuracy based on samples tested to date.